HONG KONG – China's Luye Pharma Group Ltd. has emerged as a global biotech player by leveraging partnerships around the world, and its 24-year journey is a case study of how a Chinese company can expand, both acquire and protect intellectual property (IP) and deal with cultural challenges that come with global operations.